Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 766 | 3,735 | 1,282 | 15,036 | 8,305 | 8,718 | 8,929 |
| EBITDA | 24 | 825 | -1,174 | 5,527 | -59 | -148 | -469 |
| Net profit | 35 | 818 | -958 | 5,104 | -857 | -552 | -540 |
| Total assets | 4,070 | 2,613 | 3,149 | 10,797 | 14,842 | 13,732 | 9,386 |
| n (companies reporting) | 2 | 2 | 3 | 4 | 5 | 4 | 4 |
GEL, thousands
| Company | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Neolabi | 766 | 1,038 | 0 | 10,364 | 3,426 | 1,932 | 2,347 |
| Mrcheveli-Batumi | — | — | — | 0 | 1,365 | 1,738 | 2,310 |
| Jandatsvis Saertashoris… | 0 | 2,697 | 783 | 637 | 1,329 | 2,302 | 2,161 |
| Kromos Pharma Sakartvelo | — | — | — | — | 0 | 2,746 | 2,110 |
| In Taim Diagnostik Geor… | — | — | 499 | 4,034 | 2,185 | — | — |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2018–FY2024 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.